Eco Science Solutions Inc
ESSI
$0.0151 -2.58%
Exchange: OTC | Sector: Healthcare | Industry: Medical Healthcare Information Services
Q3 2025
Published: Dec 16, 2024

Earnings Highlights

  • EPS of $-0.01 increased by 7.1% from previous year
  • Net income of -275.31K
  • "N/A" - N/A

Eco Science Solutions Inc (ESSI) QQ3 2025 Results — Challenging Liquidity Position and Narrowing Losses in Cannabis-Tech Healthcare IT

Executive Summary

Eco Science Solutions Inc (ESSI) reported QQ3 2025 results with a continued negative bottom line and a fragile liquidity position. The quarter shows an operating loss of $255,992 and a net loss of $275,311, with earnings per share of -$0.0052. Despite no revenue data disclosed for the period, fixed cost structures (R&D $86,081 and G&A $169,911) contributed to total operating expenses of $255,992, alongside interest expense of $19,319. Net cash from operating activities was negative at $76,047, and the company finished the period with a cash balance of only $4,100, underscoring a stretched liquidity profile. On the balance sheet, total assets stood at $104,100 while total liabilities reached $16.38 million, yielding a negative stockholders’ equity of $16.28 million. Short-term debt of $6.81 million remains a meaningful funding obligation, and the cash ratio, current ratio, and other liquidity metrics imply an elevated risk of sustained liquidity pressure. Year-over-year and quarter-over-quarter metrics present a bifurcated picture: operating income and net income show modest YoY improvements (operating income up 7.25% YoY and net income up 6.36% YoY, per the provided ratios) but deteriorate QoQ (-11.34% for operating income and -10.52% for net income). EPS improved 7.14% YoY but declined 10.64% QoQ. The lack of disclosed revenue data constrains a holistic assessment of top-line progression, making profitability and cash flow the dominant drivers of the investment thesis for ESSI in the near term. Management commentary from the earnings call is not provided in the dataset, limiting insight into strategic actions and forward guidance.

Key Performance Indicators

Operating Income

-255.99K
QoQ: -11.34% | YoY:7.25%

Net Income

-275.31K
QoQ: -10.52% | YoY:6.36%

EPS

-0.01
QoQ: -10.64% | YoY:7.14%

Revenue Trend

Margin Analysis

Key Insights

  • Operating income: -$255,992; EBITDA: -$255,992; Net income: -$275,311; EPS: -$0.0052.
  • YoY change (operating income): +7.25%; QoQ: -11.34%.
  • Net income YoY: +6.36%; QoQ: -10.52%; EPS YoY: +7.14%; QoQ: -10.64%.
  • Net cash provided by operating activities: -$76,047.
  • Free cash flow: -$76,047.

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2026 0.00 -0.01 +0.0% View
Q1 2026 0.00 -0.01 +0.0% View
Q3 2025 0.00 -0.01 +0.0% View
Q2 2025 0.00 0.00 +0.0% View
Q1 2025 0.00 -0.01 +0.0% View